Better Biotech Bets: Ovid’s Strategic Rise in Neurological Drugs
Better biotech bets start with understanding who’s really innovating. Ovid Therapeutics is making serious moves in the neurological drug space — and if you’re not watching them, you’re probably missing one of the stealthiest risers in biotech right now. New Pipeline, New Power Moves for Better Biotech Bets Ovid isn’t throwing spaghetti at the wall…